Featured Research

from universities, journals, and other organizations

Intimate Kissing Quadruples Risk Of Meningitis In Teenagers

Date:
February 10, 2006
Source:
BMJ-British Medical Journal
Summary:
Intimate kissing with multiple partners almost quadruples a teenager's risk of meningococcal disease, finds a study published online by the British Medical Journal.

Intimate kissing with multiple partners almost quadruples a teenager's risk of meningococcal disease, finds a study published online by the British Medical Journal.

Meningococcal disease is a life threatening condition with two incidence peaks: in early childhood and in adolescence.

The incidence and fatality rate among teenagers in England and the United States rose dramatically during the 1990s, but little is known about the risk factors for this disease in adolescents.

The research team examined potential risk and protective factors in 15-19 year olds who had been admitted to hospital with meningococcal disease in six regions of England from January 1999 to June 2000. Each case was compared with a matched control. Blood samples and nose and throat swabs were taken and data on potential risk factors were gathered by confidential interview.

Intimate kissing with multiple partners, a history of preceding illness, and being a student conferred higher risk of disease, whereas recent attendance at a religious event and meningococcal vaccination were associated with lower risk.

Despite some study limitations, these findings imply that changing personal behaviours could reduce the risk of meningococcal disease in adolescence, say the authors.

Although behaviour based health promotion messages might have a small role in reducing the risk of disease, such campaigns are unlikely to have a major impact. The development of further effective meningococcal vaccines therefore remains a key public health priority, they conclude.


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Cite This Page:

BMJ-British Medical Journal. "Intimate Kissing Quadruples Risk Of Meningitis In Teenagers." ScienceDaily. ScienceDaily, 10 February 2006. <www.sciencedaily.com/releases/2006/02/060210090713.htm>.
BMJ-British Medical Journal. (2006, February 10). Intimate Kissing Quadruples Risk Of Meningitis In Teenagers. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/02/060210090713.htm
BMJ-British Medical Journal. "Intimate Kissing Quadruples Risk Of Meningitis In Teenagers." ScienceDaily. www.sciencedaily.com/releases/2006/02/060210090713.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins